Composition for regulating and improving blood glucose

A Bacillus velezensis KMU01-derived composition addresses the limitations of existing diabetes treatments by reducing blood glucose and regulating insulin secretion, providing a safer and more effective therapeutic option.

WO2026110978A1PCT designated stage Publication Date: 2026-05-28KOOKMINBIO CORP
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
KOOKMINBIO CORP
Filing Date
2024-11-25
Publication Date
2026-05-28

AI Technical Summary

Technical Problem

Current treatments for metabolic diseases such as diabetes mellitus, including sulfonylureas, biguanides, and thiazolidinedione drugs, suffer from significant side effects and incomplete therapeutic efficacy, necessitating the development of new compositions for blood sugar control and improvement.

Method used

A composition comprising the fermentation culture supernatant, concentrate, or dried product of Bacillus velezensis KMU01 strain (previously known as Bacillus polyfermenticus KMU01) is used to regulate insulin secretion and lower fasting blood glucose levels, potentially including dead bacteria or spores, organic acids, and amino acids.

Benefits of technology

The composition effectively reduces fasting blood glucose levels and regulates serum insulin secretion, offering a safer and more effective alternative to existing treatments by potentially preventing and treating insulin-related complications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure KR2024018703_28052026_PF_FP_ABST
    Figure KR2024018703_28052026_PF_FP_ABST
Patent Text Reader

Abstract

The present invention relates to a pharmaceutical composition and a health functional food composition for regulating and improving blood glucose, each comprising, as an active ingredient, a fermented culture supernatant of a Bacillus velezensis KMU01 strain, a concentrate thereof, a dried product thereof, a fermentation metabolite thereof, or a mixture thereof, and having the effects of regulating insulin secretion in serum and lowering fasting blood glucose.
Need to check novelty before this filing date? Find Prior Art